Brief: Ekso Bionics Reports Fourth Quarter and Full-Year 2024 Financial Results
03/03/2025 21:59
March 3 (Reuters) - Ekso Bionics Holdings Inc EKSO.O: EKSO BIONICS Q4 INCOME FROM OPERATIONS USD -2.23 MILLION EKSO BIONICS Q4 NET INCOME USD -3.413 MILLION EKSO BIONICS Q4 OPERATING EXPENSES USD 4.944 MILLION EKSO BIONICS Q4 GROSS PROFIT USD 2.714 MILLION EKSO BIONICS Q4 REVENUE USD 5.09 MILLION EKSO BIONICS HOLDINGS INC - Q4 LOSS PER SHARE $0.14 Source text: ID:nGNX594g2V Further company coverage: EKSO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chronoscale
See all newsBrief: Chronoscale To Divest Ekso Bionics And Focus On Cloud Business
Brief: Applied Digital Completes Separation Of Cloud Business, Establishing Chronoscale As Independent Public Company
Brief: Ekso Bionics Holdings On Feb 15, Enters Agreement With Apld Intermediate
Applied Digital jumps after Q2 revenue beats on AI data center demand
Applied Digital beats quarterly revenue estimates on AI data center demand, shares jump